Company Quick10K Filing
CVR Partners
10-Q 2020-06-30 Filed 2020-08-04
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-02-20
10-Q 2019-09-30 Filed 2019-10-24
10-Q 2019-06-30 Filed 2019-07-25
10-Q 2019-03-31 Filed 2019-04-25
10-K 2018-12-31 Filed 2019-02-21
10-Q 2018-09-30 Filed 2018-10-25
10-Q 2018-06-30 Filed 2018-07-26
10-Q 2018-03-31 Filed 2018-04-26
10-K 2017-12-31 Filed 2018-02-23
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-02-21
10-Q 2016-09-30 Filed 2016-10-28
10-Q 2016-06-30 Filed 2016-07-29
10-Q 2016-03-31 Filed 2016-04-29
10-K 2015-12-31 Filed 2016-02-18
10-Q 2015-09-30 Filed 2015-10-29
10-Q 2015-06-30 Filed 2015-07-30
10-Q 2015-03-31 Filed 2015-05-01
10-K 2014-12-31 Filed 2015-02-20
10-Q 2014-09-30 Filed 2014-10-31
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-02-26
10-Q 2013-09-30 Filed 2013-11-04
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-05-02
10-K 2012-12-31 Filed 2013-03-01
10-Q 2012-09-30 Filed 2012-11-06
10-Q 2012-06-30 Filed 2012-08-02
10-Q 2012-03-31 Filed 2012-05-04
10-K 2011-12-31 Filed 2012-02-24
10-Q 2011-09-30 Filed 2011-11-04
10-Q 2011-06-30 Filed 2011-08-08
10-Q 2011-03-31 Filed 2011-05-11
8-K 2020-08-03 Earnings, Regulation FD, Exhibits
8-K 2020-05-06
8-K 2020-04-20
8-K 2020-02-19
8-K 2019-11-20
8-K 2019-10-23
8-K 2019-07-24
8-K 2019-05-14
8-K 2019-04-24
8-K 2019-02-20
8-K 2018-11-13
8-K 2018-10-24
8-K 2018-09-28
8-K 2018-09-18
8-K 2018-07-25
8-K 2018-05-02
8-K 2018-04-26
8-K 2018-03-23
8-K 2018-02-22
8-K 2018-02-22

CVR Partners Financials

UAN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
CF Industries (CF) 10,825 25% 9.6 4% 12,902 9,922 4,673 1,189 552 1,510 14,556
Mosaic (MOS) 7,691 12% 18.6 -1% 20,440 10,340 6,830 817 -140 621 11,565
Israel Chemicals (ICL) 7,464 0% 8,776 4,861 0 0 0 0 7,464
Scotts Miracle-Gro (SMG) 5,761 32% 10.0 15% 3,029 2,306 3,156 1,020 461 739 7,408
American Vanguard (AVD) 462 39% 15.1 3% 681 343 469 184 18 41 621
United States Lime & Minerals (USLM) 461 25% 9.1 9% 274 31 155 39 25 42 381
Resolute Forest Products (RFP) 455 22% 5.7 2% 3,671 2,119 3,187 695 60 136 770
CVR Partners (UAN) 452 14% 20.6 -1% 1,180 728 416 59 -11 48 1,000
Verso (VRS) 442 5% 2.0 2% 1,635 768 2,552 116 40 228 458
Luxfer (LXFR) 436 24% 25.9 -1% 402 223 455 110 -3 20 530
Marrone (MBII) 212 53% -5.9 -50% 78 54 21 11 -39 -37 221
Calyxt (CLXT) 198 -13% -3.9 -35% 96 24 3 -0 -34 -33 130
Evogene (EVGN) 81 0% 59 0 0 0 0 79
Senestech (SNES) 28 27% -3.6 -110% 7 1 0 0 -7 -7 25
China Green Agriculture (CGA) 23 21% -7.8 -1% 463 81 287 61 -5 8 -59
Arcadia Biosciences (RKDA) 2 0% 0.8 -60% 37 23 1 0 -23 -22 -18
Nutrien (NTR)
Bioceres Crop Solutions (BIOX) 0% 242 180 0 0 0 0 -0

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash23025623722619618012815311287858678688073673350527665568252704961286162976984
Accounts Receivable6896587115881187710108791613141514121015282162172315
Inventory23262322233029323333333431333634363738335357586462585458505764725657
PP&E3323363413554925175435535635665705735785835895915966016026041,3891,3921,4001,4021,4051,4071,4111,4141,4191,4231,4281,4291,4311,427
Assets6416746596576406536236606195945935935755625795685605245365291,3531,3271,3121,3281,2811,2761,2341,2391,2001,2191,2541,2471,1901,180
Accounts Payable13151621183234222220171416141313151911113422292625212424252027192129
Long-Term Debt125125125125125125125125125125125125125125125125125125125125649649647647647647647647647647629630631632
Liabilities157185170179163187177191158156154162155153165154152157151145681687687714672699684709685717755767699728
Stockholders' Equity484489489478477466446469461439440430420409414414408367386384625550500
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8177887881756881896984808867749381496673120788585986978809380989213889
Cost of Revenue7773807982788771759788
Gross Profit81218-10-426917411
R&D
SG&A44556668777667676766
Tax00-0000-00000000-00-00-000000000-000-000
Net Income3836413035321536352028211713253027-131918-17-13-15-10-3-32-27-19-16-13-1-619-23
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating5832544595717223236242039253112124618-3302114-274052-1734
Cash Investing-2-9-22-17-25-18-14-4-8-3-4-6-8-3-3-6-5-2-74-6-5-4-3-3-6-6-4-2-4
Cash Financing-30-42-43-44-36-14-45-43-27-31-28-24-20-30-33-29-0-2093-23-2000-14-8-16